A group of 55 children with Down's Syndrome (mongolism) were clinically diagnosed and separated into two groups. Of those less than 3½ years of age, 15 were treated, while 13 were controls. In the older group (up to 14 years of age), 16 were treated and 11 were controls. This division was made as both groups are considered representative, the first being formed by children in the period of the development of the central nervous system, and the second by children that are only in the learning stage.
DMSO and amino acids were administered by intramuscular injections in different rhythms over 200 days in the older group and over a year+ in the younger group. Several of them have continued with support treatments of 2 injections a week.
Eventually, in the DMSO treated groups, we observed the appearance of a moderate nasal bridge and the decrease of the vertical fold of skin over the corner of the eyes. In the majority, the abnormally large tongue seen in Down's Syndrome diminished or disappeared and hair became more abundant whilst the neck became thinner. Their chests became more normal with the increase of abdominal muscular tone and the umbilical hernias were less frequent. Also some cases of squint improved and voices became higher. We observed favourable increases in motor skills, adaptive, language and social areas.
Finally we want to emphasize that even though we have not arrived at an ideal treatment, we have reached a new stage in this difficult field of medicine, in which there has been no other progress for several decades. Aspillaga MJ, Dimethyl sulfoxide therapy in severe retardation in mongoloid children. Ann N Y Acad Sci. 1975 Jan 27;243:421-31. PMID:124151.
Directions for Use: Take 5ml (tsp) (3500mg) of
70% DMSO and 30% water in a glass of fresh juice 3 or 4 times a day.